Business Description
RTW Biotech Opportunities Ltd
ISIN : GG00BKTRRM22
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.96 | |||||
Debt-to-EBITDA | N/A | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 7/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -18.1 | |||||
3-Year EPS without NRI Growth Rate | -18.7 | |||||
3-Year Book Growth Rate | -1.8 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.73 | |||||
9-Day RSI | 48 | |||||
14-Day RSI | 48.11 | |||||
6-1 Month Momentum % | 13.16 | |||||
12-1 Month Momentum % | 6.83 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.2 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Net Margin % | 96.4 | |||||
FCF Margin % | 38.87 | |||||
ROE % | 21.56 | |||||
ROA % | 19.74 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 3.68 | |||||
PE Ratio without NRI | 3.68 | |||||
PS Ratio | 3.54 | |||||
PB Ratio | 0.65 | |||||
Price-to-Tangible-Book | 0.64 | |||||
Price-to-Free-Cash-Flow | 9.2 | |||||
Price-to-Operating-Cash-Flow | 9.2 | |||||
EV-to-Revenue | 5.81 | |||||
EV-to-FCF | 15.13 | |||||
Price-to-Graham-Number | 0.32 | |||||
FCF Yield % | 6.65 |